Pao‐Yu Chen

720 total citations
26 papers, 417 citations indexed

About

Pao‐Yu Chen is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Pao‐Yu Chen has authored 26 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 12 papers in Epidemiology and 9 papers in Clinical Biochemistry. Recurrent topics in Pao‐Yu Chen's work include Bacterial Identification and Susceptibility Testing (9 papers), Antimicrobial Resistance in Staphylococcus (9 papers) and Antifungal resistance and susceptibility (8 papers). Pao‐Yu Chen is often cited by papers focused on Bacterial Identification and Susceptibility Testing (9 papers), Antimicrobial Resistance in Staphylococcus (9 papers) and Antifungal resistance and susceptibility (8 papers). Pao‐Yu Chen collaborates with scholars based in Taiwan, United Kingdom and United States. Pao‐Yu Chen's co-authors include Jann‐Tay Wang, Shan‐Chwen Chang, Yu‐Chung Chuang, Yee‐Chun Chen, Wang‐Huei Sheng, Chi‐Ying Lin, Yi‐Chien Lee, Hsin‐Yun Sun, Chou-Han Lin and Hsin‐Yi Lin and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and Critical Care Medicine.

In The Last Decade

Pao‐Yu Chen

24 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pao‐Yu Chen Taiwan	13	305	197	134	89	70	26	417
Rita Dhar Kuwait	13	288 0.9×	223 1.1×	80 0.6×	48 0.5×	29 0.4×	29	443
Turid Snekloth Søndergaard Denmark	11	267 0.9×	159 0.8×	152 1.1×	125 1.4×	24 0.3×	18	438
Eric M. Ransom United States	13	203 0.7×	111 0.6×	75 0.6×	68 0.8×	28 0.4×	27	413
Simeng Duan China	12	138 0.5×	134 0.7×	62 0.5×	107 1.2×	65 0.9×	19	308
Elia Gómez G. de la Pedrosa Spain	11	308 1.0×	279 1.4×	39 0.3×	96 1.1×	42 0.6×	22	500
A. Kunová Slovakia	13	307 1.0×	285 1.4×	123 0.9×	57 0.6×	33 0.5×	28	526
P. Gialanella United States	11	297 1.0×	167 0.8×	95 0.7×	33 0.4×	24 0.3×	12	406
Carlos Garcés Colombia	9	178 0.6×	74 0.4×	75 0.6×	61 0.7×	45 0.6×	18	317
Maria Tsivitanidou Greece	10	191 0.6×	190 1.0×	36 0.3×	115 1.3×	94 1.3×	14	386
Maria Goreth Barberino Brazil	9	155 0.5×	151 0.8×	63 0.5×	75 0.8×	17 0.2×	18	296

Countries citing papers authored by Pao‐Yu Chen

Since Specialization

Citations

This map shows the geographic impact of Pao‐Yu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pao‐Yu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pao‐Yu Chen more than expected).

Fields of papers citing papers by Pao‐Yu Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pao‐Yu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pao‐Yu Chen. The network helps show where Pao‐Yu Chen may publish in the future.

Co-authorship network of co-authors of Pao‐Yu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Pao‐Yu Chen. A scholar is included among the top collaborators of Pao‐Yu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pao‐Yu Chen. Pao‐Yu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Pao‐Yu, et al.. (2024). Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients. Journal of Antimicrobial Chemotherapy. 79(5). 1196–1200. 1 indexed citations

Chen, Pao‐Yu, Chien‐Ming Chao, Chwan-Yau Luo, et al.. (2024). Emerging Aspergillus lentulus infections in Taiwan: clinical and environmental surveillance. JAC-Antimicrobial Resistance. 6(4). dlae138–dlae138.

Chen, Pao‐Yu, Yu‐Shan Huang, Yu‐Chung Chuang, et al.. (2024). Implication of genotypes for prognosis of Candida glabrata bloodstream infections. Journal of Antimicrobial Chemotherapy. 79(8). 2008–2016.

Huang, Yu‐Shan, et al.. (2023). In vitro activity of cefiderocol and comparator antibiotics against multidrug-resistant non-fermenting Gram-negative bacilli. JAC-Antimicrobial Resistance. 6(1). dlae006–dlae006. 8 indexed citations

Chen, Pao‐Yu, Jann‐Tay Wang, Sui‐Yuan Chang, et al.. (2023). Factors associated with viral rebound among COVID-19 patients receiving oral antivirals. Journal of the Formosan Medical Association. 122(8). 766–775. 5 indexed citations

Chen, Pao‐Yu, Jann‐Tay Wang, & Shan‐Chwen Chang. (2023). Antiviral therapy of coronavirus disease 2019 (COVID-19). Journal of the Formosan Medical Association. 123. S47–S54. 4 indexed citations

Chen, Pao‐Yu, Ting‐Yu Yen, Chun‐Yi Lu, et al.. (2021). Comparisons of the clinical and mycological characteristics of pediatric candidemia. Journal of the Formosan Medical Association. 121(9). 1668–1679. 2 indexed citations

Huang, Yu‐Shan, Wan‐Chen Tsai, Jiajie Li, et al.. (2021). Increasing New Delhi metallo-β-lactamase-positive Escherichia coli among carbapenem non-susceptible Enterobacteriaceae in Taiwan during 2016 to 2018. Scientific Reports. 11(1). 2609–2609. 18 indexed citations

Chen, Pao‐Yu, Yu‐Chung Chuang, Un‐In Wu, et al.. (2021). Mechanisms of Azole Resistance and Trailing in Candida tropicalis Bloodstream Isolates. Journal of Fungi. 7(8). 612–612. 25 indexed citations

10.

Chen, Pao‐Yu, Yu‐Chung Chuang, Jann‐Tay Wang, et al.. (2021). Sequence type 8 as an emerging clone of methicillin-resistant Staphylococcus aureus causing bloodstream infections in Taiwan. Emerging Microbes & Infections. 10(1). 1908–1918. 13 indexed citations

11.

Huang, Yu-Ting, et al.. (2021). Comparison of Bleeding Risk Between Colistin–Tigecycline and Colistin–Carbapenem Treatment Regimens: A Retrospective Cohort Study. Infection and Drug Resistance. Volume 14. 4949–4955. 3 indexed citations

12.

Lee, Yi‐Chien, Pao‐Yu Chen, Jann‐Tay Wang, & Shan‐Chwen Chang. (2020). Prevalence of fosfomycin resistance and gene mutations in clinical isolates of methicillin-resistant Staphylococcus aureus. Antimicrobial Resistance and Infection Control. 9(1). 135–135. 18 indexed citations

13.

Chen, Pao‐Yu, Yu‐Chung Chuang, Jann‐Tay Wang, et al.. (2019). Predictors for vancomycin resistant Enterococcus faecium transforming from colonization to infection: a case control study. Antimicrobial Resistance and Infection Control. 8(1). 196–196. 11 indexed citations

14.

Lee, Yi‐Chien, Pao‐Yu Chen, Jann‐Tay Wang, & Shan‐Chwen Chang. (2019). A study on combination of daptomycin with selected antimicrobial agents: in vitro synergistic effect of MIC value of 1 mg/L against MRSA strains. BMC Pharmacology and Toxicology. 20(1). 25–25. 28 indexed citations

15.

Chuang, Yu‐Chung, Pao‐Yu Chen, Chi‐Ying Lin, et al.. (2018). A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections. Scientific Reports. 8(1). 1632–1632. 20 indexed citations

16.

Lin, Kuan‐Yin, Pao‐Yu Chen, Yu‐Chung Chuang, et al.. (2018). Effectiveness of echinocandins versus fluconazole for treatment of persistent candidemia: A time-dependent analysis. Journal of Infection. 77(3). 242–248. 10 indexed citations

17.

Chuang, Yu‐Chung, Hsin‐Yi Lin, Pao‐Yu Chen, et al.. (2016). Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose. Clinical Microbiology and Infection. 22(10). 890.e1–890.e7. 53 indexed citations

18.

Chen, Pao‐Yu, Yu‐Chung Chuang, Jann‐Tay Wang, & Shan‐Chwen Chang. (2015). Impact of Prior Healthcare-Associated Exposure on Clinical and Molecular Characterization of Methicillin-Susceptible Staphylococcus aureus Bacteremia. Medicine. 94(5). e474–e474. 12 indexed citations

19.

Ho, Chao‐Chi, Dar-Der Ji, Chang Min Lee, et al.. (2012). Etiology of pulmonary complications of human immunodeficiency virus-1-infected patients in Taiwan in the era of combination antiretroviral therapy: A prospective observational study. Journal of Microbiology Immunology and Infection. 46(6). 433–440. 12 indexed citations

20.

Chen, Pao‐Yu, Yu‐Chung Chuang, Jann‐Tay Wang, et al.. (2012). Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010. Journal of Microbiology Immunology and Infection. 47(2). 95–103. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact